PTPN22 and neoplasm: Xenograft assays revealed that the tumour burden in the nude mice injected with fMWNTs/MBD1siRNA and LyP‐1‐fMWNTs/MBD1siRNA was relieved than that in the nude mice injected with saline and MBD1siRNA.